rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Khursheed Anwer

Chief Scientific Officer

Company insider

Files Form 4 as: Chief Scientific Officer, Imunon.

In numbers

Trades disclosed
15
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
0
First trade
20 Jun 2014
Last trade
2 Jan 2026
Last filed
6 Jan 2026

Companies traded

Where they are an officer
IMNN ImunonOfficer · Biotechnology · last 2 Jan 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
2 Jan 2026filed 6 Jan 2026IMNN Imunonoption or derivative · BiotechnologySEC FORM 4 Code A—15,736 at $0.00filing
2 Jan 2026filed 6 Jan 2026IMNN Imunonoption or derivative · BiotechnologySEC FORM 4 Code A—15,736 at $0.00filing
4 Aug 2025filed 6 Aug 2025IMNN Imunonoption or derivative · BiotechnologySEC FORM 4 Code A—1,667 at $0.00filing
6 Sep 2024filed 10 Sep 2024IMNN Imunonoption or derivative · BiotechnologySEC FORM 4 Code A—40,653 at $0.00filing
12 Jun 2024filed 14 Jun 2024IMNN Imunonoption or derivative · BiotechnologySEC FORM 4 Code A—25,000 at $0.00filing
15 Mar 2024filed 18 Mar 2024IMNN Imunonoption or derivative · BiotechnologySEC FORM 4 Code A—25,000 at $0.00filing
14 Mar 2024filed 18 Mar 2025IMNN Imunonoption or derivative · BiotechnologySEC FORM 4 Code A—25,000 at $0.00filing
17 Mar 2023filed 21 Mar 2023IMNN Imunonoption or derivative · BiotechnologySEC FORM 4 Code A—40,000 at $0.00filing
15 May 2018filed 16 May 2018IMNN Imunonoption or derivative · BiotechnologySEC FORM 4 Code A—100,000 at $0.00filing
30 May 2017filed 1 Jun 2017IMNN Imunonoption or derivative · BiotechnologySEC FORM 4 Code A—21,786 at $0.00filing
2 Feb 2016filed 4 Feb 2016IMNN Imunonoption or derivative · BiotechnologySEC FORM 4 Code A—40,000 at $0.00filing
17 Mar 2015filed 17 Mar 2015IMNN Imunonoption or derivative · BiotechnologySEC FORM 4 Code A—37,500 at $0.00filing
20 Jun 2014filed 24 Jun 2014IMNN ImunonBiotechnologySEC FORM 4 Code A$18K5,000 at $3.50filing
20 Jun 2014filed 24 Jun 2014IMNN Imunonoption or derivative · BiotechnologySEC FORM 4 Code A—40,000 at $0.00filing
20 Jun 2014filed 24 Jun 2014IMNN Imunonoption or derivative · BiotechnologySEC FORM 4 Code A—35,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Michael H. TardugnoExecutive Chairman of Board · Executive Chairman of Board at Imunon, filing Form 4 there in the last year
Stacy LindborgPresident and CEO · President and CEO at Imunon, filing Form 4 there in the last year
Douglas Vincent FallerChief Medical Officer · Chief Medical Officer at Imunon, filing Form 4 there in the last year
Susan EylwardGeneral Counsel and Corp Sec · General Counsel and Corp Sec at Imunon, filing Form 4 there in the last year
Donald P. BraunDirector · Director at Imunon, filing Form 4 there in the last year